Please try another search
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company’s Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Name | Age | Since | Title |
---|---|---|---|
Shigenobu Maekawa | 68 | 2005 | Chairman |
Toru Nakai | - | 2019 | President & Director |
Takashi Takaya | 62 | 2018 | GM of Personnel, General Affairs, Risk Mgmt, Compliance & Digital Trans and Director |
Shouzou Sano | 63 | 2015 | MD of Sales & Marketing and Director |
Yukari Kobayashi | 60 | 2021 | Independent External Director |
Kenji Kuwabara | 65 | 2020 | Standing Corporate Auditor |
Yoshinao Wada | 73 | 2019 | Independent External Director |
Miyuki Sakurai | 59 | 2017 | Independent External Director |
Mayumi Nishi | - | 2023 | Independent External Director |
Hiroharu Hara | 63 | 2023 | External Auditor |
Hirotsugu Ito | 61 | 2023 | Standing Corporate Auditor |
Tsuyoshi Kondo | - | 2016 | External Auditor |
Hitoshi Ishizawa | 63 | 2018 | GM of Functional Food Division & Director |
Kazuchika Takagaki | 63 | 2017 | GM of Research and Development Division & Director |
Takanori Edamitsu | 61 | 2018 | Head of Business Management & Sustainability and Director |
Hitomi Kimura | 63 | 2021 | GM of Resource Procurement, Production and Assurance Div. & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review